- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebral Ischemia in Patients on Direct Oral Anticoagulants
Authors
Keywords
-
Journal
STROKE
Volume 50, Issue 4, Pages 873-879
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-03-11
DOI
10.1161/strokeaha.118.023877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation
- (2017) Simon Hellwig et al. EUROPACE
- Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
- (2017) David J. Seiffge et al. Journal of Stroke
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Dabigatran Plasma Levels in Acute Cerebrovascular Events
- (2016) Bastian Volbers et al. Journal of Stroke & Cerebrovascular Diseases
- Coagulation Testing in Acute Ischemic Stroke Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Dabigatran Plasma Levels in Acute Cerebrovascular Events
- (2016) Bastian Volbers et al. Journal of Stroke & Cerebrovascular Diseases
- Recanalization Therapies in Acute Ischemic Stroke PatientsCLINICAL PERSPECTIVES
- (2015) David J. Seiffge et al. CIRCULATION
- Antithrombotic Treatment at Onset of Stroke with Atrial Fibrillation, Functional Outcome, and Fatality: A Systematic Review and Meta-Analysis
- (2015) Niamh Hannon et al. International Journal of Stroke
- Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol
- (2015) Jessica Kepplinger et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
- (2014) Walter N. Kernan et al. STROKE
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke
- (2012) Waltraud Pfeilschifter et al. ANNALS OF NEUROLOGY
- Impact of Anticoagulation before Stroke on Stroke Severity and Long-Term Survival
- (2011) Karl Georg Haeusler et al. International Journal of Stroke
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Admission international normalized ratio and acute infarct volume in ischemic stroke
- (2008) Hakan Ay et al. ANNALS OF NEUROLOGY
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
- (2008) Werner Hacke et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started